Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12804389rdf:typepubmed:Citationlld:pubmed
pubmed-article:12804389lifeskim:mentionsumls-concept:C0005064lld:lifeskim
pubmed-article:12804389lifeskim:mentionsumls-concept:C0543891lld:lifeskim
pubmed-article:12804389pubmed:issue2lld:pubmed
pubmed-article:12804389pubmed:dateCreated2003-6-13lld:pubmed
pubmed-article:12804389pubmed:abstractTextTardive dyskinesia (TD) is a potentially disfiguring movement disorder of the orofacial region often caused by the use of neuroleptic drugs. A wide range of strategies have been used to help manage tardive dyskinesia and, for those who are unable to have their antipsychotic medication stopped or substantially changed, the benzodiazepine group of drugs has been suggested as a useful adjunctive treatment.lld:pubmed
pubmed-article:12804389pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12804389pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12804389pubmed:languageenglld:pubmed
pubmed-article:12804389pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12804389pubmed:citationSubsetIMlld:pubmed
pubmed-article:12804389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12804389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12804389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12804389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12804389pubmed:statusMEDLINElld:pubmed
pubmed-article:12804389pubmed:issn1469-493Xlld:pubmed
pubmed-article:12804389pubmed:authorpubmed-author:SoaresK VKVlld:pubmed
pubmed-article:12804389pubmed:authorpubmed-author:UmbrichPPlld:pubmed
pubmed-article:12804389pubmed:issnTypeElectroniclld:pubmed
pubmed-article:12804389pubmed:ownerNLMlld:pubmed
pubmed-article:12804389pubmed:authorsCompleteYlld:pubmed
pubmed-article:12804389pubmed:paginationCD000205lld:pubmed
pubmed-article:12804389pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:12804389pubmed:meshHeadingpubmed-meshheading:12804389...lld:pubmed
pubmed-article:12804389pubmed:meshHeadingpubmed-meshheading:12804389...lld:pubmed
pubmed-article:12804389pubmed:meshHeadingpubmed-meshheading:12804389...lld:pubmed
pubmed-article:12804389pubmed:meshHeadingpubmed-meshheading:12804389...lld:pubmed
pubmed-article:12804389pubmed:meshHeadingpubmed-meshheading:12804389...lld:pubmed
pubmed-article:12804389pubmed:meshHeadingpubmed-meshheading:12804389...lld:pubmed
pubmed-article:12804389pubmed:meshHeadingpubmed-meshheading:12804389...lld:pubmed
pubmed-article:12804389pubmed:year2003lld:pubmed
pubmed-article:12804389pubmed:articleTitleBenzodiazepines for neuroleptic-induced tardive dyskinesia.lld:pubmed
pubmed-article:12804389pubmed:affiliationBootham Park Hospital York, NHS Trust, York, Yorkshire, UK. umbrich3@aol.comlld:pubmed
pubmed-article:12804389pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12804389pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12804389lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12804389lld:pubmed